VALSARTAN/HCT SANDOZ 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

valsartan, Quantity: 160 mg; hydrochlorothiazide, Quantity: 25 mg

Available from:

Novartis Pharmaceuticals Australia Pty Ltd

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; colloidal anhydrous silica; hypromellose; purified talc; iron oxide yellow; macrogol 4000; iron oxide red; iron oxide black; titanium dioxide

Administration route:

Oral

Units in package:

14 tablets, 30 tablets, 28 tablets, 7 tablets, 56 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Co-Diovan is indicated for the treatment of hypertension. Treatment should not be initiated with these combinations.

Product summary:

Visual Identification: brown-orange, ovaloid tablet with slightly convex faces, imprinted with "HXH" on one side and "NVR" on the reverse side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2022-03-15